Conley Emily 4
4 · Nuvalent, Inc. · Filed Jun 18, 2024
Insider Transaction Report
Form 4
Nuvalent, Inc.NUVL
Conley Emily
Director
Transactions
- Sale
Class A Common Stock
2024-06-14$78.31/sh−223$17,463→ 2,507 total - Exercise/Conversion
Class A Common Stock
2024-06-14$13.79/sh+5,000$68,950→ 7,507 total - Sale
Class A Common Stock
2024-06-14$77.52/sh−4,777$370,313→ 2,730 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-06-14−5,000→ 31,667 totalExercise: $13.79Exp: 2032-02-02→ Class A Common Stock (5,000 underlying)
Footnotes (4)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2023.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.93 to $77.81, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.87 to $78.71, inclusive.
- [F4]The shares underlying this option have vested or shall vest in equal monthly installments over the three years following February 2, 2022, subject to continued service to Nuvalent, Inc. through the applicable vesting date.